MRNA240705P117000
- 0.01
- -1.85-99.46%
Moderna Newsroom
Unpacking the Latest Options Trading Trends in Moderna
Investors with a lot of money to spend have taken a bullish stance on Moderna (NASDAQ:MRNA).And retail traders should know.We noticed this today when the trades showed up on publicly available options
AI Has 'The Hallmarks Of An Inflating Bubble,' Warns Veteran Wall Street Investor
Signs are emerging that the market boom surrounding artificial intelligence (AI) might be taking on the characteristics of a bubble.This warning comes from Wall Street veteran investor Ed Yardeni, Pre
Here's How Much $1000 Invested In Moderna 5 Years Ago Would Be Worth Today
Moderna (NASDAQ:MRNA) has outperformed the market over the past 5 years by 37.68% on an annualized basis producing an average annual return of 50.84%. Currently, Moderna has a market capitalization of
Moderna Given $176 Million to Advance Bird Flu Vaccine
A Fourth Dairy Worker Tests Positive for Bird Flu as Federal Response Ramps Up -- Barrons.com
By Josh Nathan-Kazis A Colorado dairy worker has tested positive for avian influenza, the Centers for Disease Control and Prevention said Wednesday afternoon, bringing the total number of farmers inf
GSK Will Pay Up to $1.5 Billion for CureVac's MRNA Vaccines -- Barrons.com
By Josh Nathan-Kazis The drugmaker GSK plunged into the messenger RNA-based vaccine market Wednesday, announcing it will buy the rights to experimental influenza and Covid-19 mRNA vaccines from the b
Moderna has been awarded $176 million by the US Department of Health for the development of a bird flu vaccine.
On July 3rd, Guolonghui reported that the Rapid Response Partnership Program (RRPV) of the U.S. Department of Health and Human Services provided Moderna with a project funding of $176 million to promote the development of bird flu vaccines based on mRNA technology, especially for the highly contagious H5 influenza virus. This virus not only causes serious illness in birds, but also poses the risk of transmission to humans. Moderna stated that the agreement with RRPV covers not only the current vaccine development, but also additional options prepared for future public health threats, demonstrating the company's forward-looking layout for future challenges.
Moderna Stock (NASDAQ:MRNA): Next-Gen COVID-19 Vaccine Is More Than a Rehash
Targeting bird flu! The US government has allocated $176 million for the development of the Moderna vaccine.
Moderna has disclosed that the US government has allocated $176 million to Moderna to advance research on its bird flu vaccine. In March of this year, US officials reported the first case of H5N1 virus in cows, with at least 130 infected cows and three cases of human bird flu infection in 12 states since then.
MRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment
The medical and pharmaceutical community continues to embrace emerging technologies, beginning with mRNA that rose to fame during the COVID-19 pandemic.
USA has allocated $176 million to Moderna for the production of bird flu vaccine.
The US government has allocated USD 176 million to Moderna (MRNA.US) to advance its development of bird flu vaccine. Moderna stated that the funds from the US Biomedical Advanced Research and Development Authority will be used to complete the late-stage development and testing of an mRNA-based H5N1 avian influenza vaccine before the COVID-19 pandemic. Since March of this year, concerns over H5N1 virus outbreaks in dairy cows in multiple states in the United States and three infected dairy workers have been increasing.
COVID Infections Could Be Seeing a Summer Surge Based on CDC Data
US HHS Says 8 Labs Sign Royalty-Free Agreements For H5N1 Tests; Moderna Deal Allows Pivot To Other Pandemic Threats; Too Early To Determine Moderna Vaccine Production Capacity; First H5N1 Vaccines From CSL Seqirus Ready By Mid-July
US HHS Says 8 Labs Sign Royalty-Free Agreements For H5N1 Tests; Moderna Deal Allows Pivot To Other Pandemic Threats; Too Early To Determine Moderna Vaccine Production Capacity; First H5N1 Vaccines Fro
Express News | US Cdc Official Says There Are 750,000 H5N1 Tests Available and 1.2 Million Tests Coming Online in the Next Two to Three Months
Express News | US Hhs Official Says Risk of Bird Flu Remains Low, and Vaccination Is Not Recommended for Any Segment of the Population
Express News | US Cdc Official Said the Agency Says Agency Has Been Working With Commercial Testing Labs; 8 Have Already Signed Royalty Free Agreements to Make H5N1 Tests
Express News | US Hhs Official Says Moderna Deal Would Allow the Government to Pivot to Other Pandemic Threats IF Needed
Express News | US Hhs Says Moderna Late Stage Trials of H5N1 Will Likely Start in 2025
Express News | US FDA Says Lab Experiments Confirm That Pasteurization Inactivates Milk Tainted With H5N1 Virus
Express News | US Hhs Official Says It Is Too Early to Tell How Many Doses Moderna Would Be Able to Manufacture